Mckinley Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Mckinley Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$8.75 - $13.03 $22,251 - $33,135	-2,543 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$9.51 - $16.6 $27,274 - $47,608	-2,868 Reduced 53.0%	2,543 $29,000
Q3 2018 Nov 08, 2018	SELL	$13.05 - $19.05 $5,676 - $8,286	-435 Reduced 7.44%	5,411 $92,000
Q2 2018 Jul 13, 2018	BUY	$13.9 - $19.8 $33,554 - $47,797	2,414 Added 70.34%	5,846 $83,000
Q1 2018 May 04, 2018	SELL	$16.7 - $26.35 $1.6 Million - $2.52 Million	-95,723 Reduced 96.54%	3,432 $65,000
Q4 2017 Feb 08, 2018	BUY	$11.6 - $17.35 $765 - $1,145	66 Added 0.07%	99,155 $1.63 Million
Q3 2017 Nov 13, 2017	BUY	$8.4 - $15.0 $832,347 - $1.49 Million	99,089	99,089 $1.49 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $387M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.